Valneva SE (VALN) Gross Margin (2021 - 2026)
Valneva SE (VALN) posted quarterly Gross Margin of 15.29% for Q1 2026, down 3791.0% year-on-year from 0.41% in Q1 2025, and up 142.29% on a QoQ basis from 6.31% in Q4 2025.
Valneva SE (VALN) Gross Margin (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Gross Margin for 6 consecutive years, with 15.29% the latest figure, recorded in Q1 2026.
- Quarterly Gross Margin fell 3791.0% year-over-year to 15.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.99% (down 2371.0% YoY) and the FY2025 annual result came in at 32.15%, down 751.0% from the prior year.
- Gross Margin rose to 15.29% in Q1 2026 per VALN's latest filing, from 6.31% in the prior quarter.
- Over the last five years, Gross Margin for VALN reached as high as 80.06% in Q3 2022 and fell as low as 120.83% in Q2 2022.
- A 5-year average of 23.3% and a median of 37.79% in 2023 frame the typical range for Gross Margin.
- The largest YoY upside for Gross Margin was 53861 bps in 2022 against a maximum downside of 13795 bps in 2022.
- Year by year, Gross Margin stood at 9.26% in 2022, then surged by 508 bps to 37.79% in 2023, then climbed by 23 bps to 46.39% in 2024, then sank by 86 bps to 6.31% in 2025, then jumped by 142 bps to 15.29% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 15.29%, 6.31%, and 9.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 88.95% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 90.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 15.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.29% |
| Dec 31, 2025 | 6.31% |
| Sep 30, 2025 | -9.47% |
| Jun 30, 2025 | 50.10% |
| Mar 31, 2025 | 53.20% |
| Dec 31, 2024 | 46.39% |
| Sep 30, 2024 | 38.40% |
| Jun 30, 2024 | 38.34% |
| Mar 31, 2024 | 32.34% |
| Dec 31, 2023 | 37.79% |
| Sep 30, 2023 | 44.91% |
| Jun 30, 2023 | 17.09% |
| Mar 31, 2023 | 38.88% |
| Dec 31, 2022 | -9.26% |
| Sep 30, 2022 | 80.06% |
| Jun 30, 2022 | -120.83% |
| Mar 31, 2022 | 36.56% |
| Dec 31, 2021 | 89.82% |
| Sep 30, 2021 | -458.55% |
| Jun 30, 2021 | 17.12% |